(Q43117862)

14 November 2017

title

Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension (English)

1 reference

14 November 2017

Hiroshi Fujita

1

1 reference

14 November 2017

Yoshihiro Fukumoto

2

1 reference

14 November 2017

Kenya Saji

3

1 reference

14 November 2017

Koichiro Sugimura

4

1 reference

14 November 2017

Jun Demachi

5

1 reference

14 November 2017

Jun Nawata

6

1 reference

14 November 2017

Hiroaki Shimokawa

7

1 reference

14 November 2017

publication date

26 March 2010

1 reference

14 November 2017

1 reference

14 November 2017

volume

25

1 reference

14 November 2017

issue

2

1 reference

14 November 2017

page(s)

144-149

1 reference

https://scigraph.springernature.com/pub.10.1007/s00380-009-1176-8

14 November 2017

exact match

0 references

cites work

Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats

1 reference

12 December 2020

Diagnosis and differential assessment of pulmonary arterial hypertension

1 reference

12 December 2020

Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension

1 reference

12 December 2020

Inflammation in pulmonary arterial hypertension.

1 reference

12 December 2020

Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.

1 reference

12 December 2020

Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases

1 reference

12 December 2020

Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm

1 reference

12 December 2020

Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells

1 reference

12 December 2020

Pulmonary Arterial Hypertension

1 reference

12 December 2020

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

1 reference

12 December 2020

Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats

1 reference

12 December 2020

Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina

1 reference

12 December 2020

Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice

1 reference

12 December 2020

Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension

1 reference

12 December 2020

Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension

1 reference

12 December 2020

Rho-kinase is an important therapeutic target in cardiovascular medicine

1 reference

12 December 2020

Rho kinase (ROCK) inhibitors

1 reference

12 December 2020

Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension.

1 reference

12 December 2020

Recent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitors

1 reference

12 December 2020

Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.

1 reference

12 December 2020

Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models

1 reference

12 December 2020

Cellular and molecular pathobiology of pulmonary arterial hypertension

1 reference

12 December 2020

10.1007/S00380-009-1176-8

Identifiers

DOI

1 reference

Dimensions Publication ID

14 November 2017

1046673970

0 references

1 reference